The medical device firm maintains its 2026 revenue guidance amid efforts to boost Veterans Affairs contract utilization.
ElectroCore Inc. reaffirmed its 2026 revenue growth target of approximately 30%, citing ongoing efforts to deepen utilization within Veterans Affairs contracts. The company did not adjust its outlook despite market volatility and operational challenges in the healthcare sector.
Prior guidance had projected similar growth, with the company previously highlighting VA contracts as a key revenue driver. Comparable periods showed steady progress, though execution risks remain amid broader industry headwinds.
Shares showed muted reaction in after-hours trading, reflecting investor caution over long-term execution risks.